Dr. Dwight Owen, MD
Claim this profileOhio State University Comprehensive Cancer Center
Area of expertise
Lung Cancer
Dwight Owen, MD has run 12 trials for Lung Cancer. Some of their research focus areas include:
Non-Small Cell Lung Cancer
Dwight Owen, MD has run 6 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
Ohio State University Comprehensive Cancer Center
The Ohio State University Wexner Medical Center
Clinical Trials Dwight Owen, MD is currently running
Temozolomide + Atezolizumab
for Small Cell Lung Cancer
This phase II trial studies the effects of temozolomide and atezolizumab as second or third line treatment for patients with small cell lung cancer that has spread to other places in the body (metastatic) or has come back (recurrent). Chemotherapy drugs, such as temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving temozolomide and atezolizumab as second or third line treatment may help prolong survival in patients with small cell lung cancer.
Recruiting
1 award
Phase 2
15 criteria
PBF-1129 + Nivolumab
for Lung Cancer
This trial is testing PBF-1129 and nivolumab in patients with advanced lung cancer. The goal is to see if these drugs can work together to stop cancer growth and boost the immune system's ability to fight the cancer. Nivolumab has shown effectiveness in treating various cancers, including non-small cell lung cancer.
Recruiting
3 awards
Phase 1
22 criteria
More about Dwight Owen, MD
Clinical Trial Related
1 year of experience running clinical trials · Led 13 trials as a Principal Investigator · 5 Active Clinical Trials
Treatments Dwight Owen, MD has experience with
- Atezolizumab
- Pembrolizumab
- Carboplatin
- Vismodegib
- Sunitinib Malate
- Osimertinib
Breakdown of trials Dwight Owen, MD has run
Lung Cancer
Non-Small Cell Lung Cancer
Solid Tumors
Thymic Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Dwight Owen, MD specialize in?
Dwight Owen, MD focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are EGFR positive.
Is Dwight Owen, MD currently recruiting for clinical trials?
Yes, Dwight Owen, MD is currently recruiting for 5 clinical trials in Columbus Ohio. If you're interested in participating, you should apply.
Are there any treatments that Dwight Owen, MD has studied deeply?
Yes, Dwight Owen, MD has studied treatments such as Atezolizumab, Pembrolizumab, Carboplatin.
What is the best way to schedule an appointment with Dwight Owen, MD?
Apply for one of the trials that Dwight Owen, MD is conducting.
What is the office address of Dwight Owen, MD?
The office of Dwight Owen, MD is located at: Ohio State University Comprehensive Cancer Center, Columbus, Ohio 43210 United States. This is the address for their practice at the Ohio State University Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.